Search research articles
Contact Us
Filters
Showing results (101-110 of 221) with videos related to
Page
of 23
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 14, 2025
Spatial Expression of HER2, NECTIN4, and TROP-2 in Muscle-Invasive Bladder Cancer and Metastases: Implications for Pathological and Clinical Management
Gabriel Dernbach, Marie-Lisa Eich, Mihnea P Dragomir, et al.
British Journal of Cancer
|
June 2, 2026
Spatial, temporal, and molecular heterogeneity of ADC targets in high-grade serous ovarian carcinoma
Xiaoxuan Li, Tobias Janik, Markus Möbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2016
ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer
Cristina Blaj, Agnes Bringmann, Eva Marina Schmidt, et al.
European Urology Focus
|
April 19, 2023
Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer-An Extensive Multiregional Immunohistochemical Analysis
Simon Schallenberg, Mihnea-Paul Dragomir, Philipp Anders, et al.
Current Oncology (Toronto, Ont.)
|
April 25, 2025
Correction: Dukaczewska et al. Necrosis in Preoperative Cross-Sectional Imaging and Postoperative Histology Is a Diagnostic Marker for Malignancy of Adrenocortical Tumors. <i>Curr. Oncol.</i> 2025, <i>32</i>, 25
Agata Dukaczewska, Stephan R Marticorena Garcia, Simon Ponsel, et al.
Cell Death & Disease
|
July 3, 2020
Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe
Bastian Gastl, Kathleen Klotz-Noack, Bertram Klinger, et al.
The Journal of Pathology. Clinical Research
|
November 9, 2022
Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer
Stefanie Jaitner, Elise Pretzsch, Jens Neumann, et al.
The American Journal of Gastroenterology
|
October 16, 2023
Endoscopic Features of Post-COVID-19 Cholangiopathy and Its Management Using ERCP
Silke Leonhardt, Donata Grajecki, Dominik Geisel, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 22, 2019
Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options
Philipp Jurmeister, Claudia Vollbrecht, Anke Behnke, et al.
Cancers
|
April 26, 2025
Detection of <i>ESR1</i> Mutations in Tissue and Liquid Biopsy with Novel Next-Generation Sequencing and Digital Droplet PCR Assays: Insights from Multi-Center Real Life Data of Almost 6000 Patients
Srushti Borkar, Fenja Markus, Agnes Oetting, et al.
Page
of 23
Search research articles
Search
Showing results (101-110 of 221) with videos related to
Sort By:
Page
of 23
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 14, 2025
Spatial Expression of HER2, NECTIN4, and TROP-2 in Muscle-Invasive Bladder Cancer and Metastases: Implications for Pathological and Clinical Management
Gabriel Dernbach, Marie-Lisa Eich, Mihnea P Dragomir, et al.
British Journal of Cancer
|
June 2, 2026
Spatial, temporal, and molecular heterogeneity of ADC targets in high-grade serous ovarian carcinoma
Xiaoxuan Li, Tobias Janik, Markus Möbs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2016
ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer
Cristina Blaj, Agnes Bringmann, Eva Marina Schmidt, et al.
European Urology Focus
|
April 19, 2023
Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer-An Extensive Multiregional Immunohistochemical Analysis
Simon Schallenberg, Mihnea-Paul Dragomir, Philipp Anders, et al.
Current Oncology (Toronto, Ont.)
|
April 25, 2025
Correction: Dukaczewska et al. Necrosis in Preoperative Cross-Sectional Imaging and Postoperative Histology Is a Diagnostic Marker for Malignancy of Adrenocortical Tumors. <i>Curr. Oncol.</i> 2025, <i>32</i>, 25
Agata Dukaczewska, Stephan R Marticorena Garcia, Simon Ponsel, et al.
Cell Death & Disease
|
July 3, 2020
Reduced replication origin licensing selectively kills KRAS-mutant colorectal cancer cells via mitotic catastrophe
Bastian Gastl, Kathleen Klotz-Noack, Bertram Klinger, et al.
The Journal of Pathology. Clinical Research
|
November 9, 2022
Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer
Stefanie Jaitner, Elise Pretzsch, Jens Neumann, et al.
The American Journal of Gastroenterology
|
October 16, 2023
Endoscopic Features of Post-COVID-19 Cholangiopathy and Its Management Using ERCP
Silke Leonhardt, Donata Grajecki, Dominik Geisel, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 22, 2019
Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options
Philipp Jurmeister, Claudia Vollbrecht, Anke Behnke, et al.
Cancers
|
April 26, 2025
Detection of <i>ESR1</i> Mutations in Tissue and Liquid Biopsy with Novel Next-Generation Sequencing and Digital Droplet PCR Assays: Insights from Multi-Center Real Life Data of Almost 6000 Patients
Srushti Borkar, Fenja Markus, Agnes Oetting, et al.
Page
of 23